Delisting risk
Calidi Biotherapeutics
Develops systemic oncolytic-virus platforms that deliver therapeutic payloads into tumors.
$1.32
After-hours close+0.01 (+0.76%)
At close$1.31(+0.77%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$2.94 | — |
| Mar 2026 | — | −$0.43 | — |
| Mar 2026 | −$1.56 | −$0.57 | +63.5% |
| Nov 2025 | −$1.68 | −$2.21 | −31.5% |
The latest year is open to everyone — the 9 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | — | — | — | — | — | — |
| Aug 13, 2026 | — | −$2.94 | — | — | — | — |
| Mar 30, 2026 | — | −$0.43 | — | — | — | — |
| Mar 27, 2026 | −$1.56 | −$0.57 | +63.5% | — | — | — |
| Nov 11, 2025 | −$1.68 | −$2.21 | −31.5% | — | — | — |
The latest year is open to everyone — the 9 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Apr 4, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 15, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 21, 2023 | ||||||